[1]
A. Deep, A. Kumar, S. Rungta, and S. Swaroop, “Sofosbuvir and Daclatasvir Bypassing Genotypic Investigation of Chronic Hepatitis C Infection: A Real-Life Experience at Tertiary care center in North Indian Population Sofosbuvir and Daclatasvir Bypassing Genotypic Investigation”, JEOH, vol. 20, no. 1&2, pp. 70–74, Jun. 2020.